Results 241 to 250 of about 219,275 (300)

Synergistic Effect of Essential Oils and Antifungal Agents in Fighting Resistant Clinical Isolates of Candida auris. [PDF]

open access: yesPharmaceutics
Cavallo L   +10 more
europepmc   +1 more source

Mangiferin potentiates the activity of antifungal agents against fluconazole-resistant <i>Candida</i> spp. [PDF]

open access: yesFuture Microbiol
Ferreira TL   +14 more
europepmc   +1 more source

Small molecule inhibitors of fungal Δ(9) fatty acid desaturase as antifungal agents against Candida auris. [PDF]

open access: yesFront Cell Infect Microbiol
Tebbji F   +6 more
europepmc   +1 more source

An 11‐Month‐Old Infant With Unusual Diaper Dermatitis

open access: yes
JEADV Clinical Practice, EarlyView.
Majda Chaoui   +2 more
wiley   +1 more source

Emerging Deep Cutaneous Fungal Infection Caused by Cyphellophora Species in a Diabetic Patient

open access: yes
The Kaohsiung Journal of Medical Sciences, EarlyView.
Yi‐Shan Teng   +2 more
wiley   +1 more source
Some of the next articles are maybe not open access.

Related searches:

Antifungal agents

Medical Journal of Australia, 2007
The four main classes of antifungal drugs are the polyenes, azoles, allylamines and echinocandins. Clinically useful "older" agents include topical azole formulations (for superficial yeast and dermatophyte infections), first-generation triazoles (fluconazole and itraconazole, for a range of superficial and invasive fungal infections), amphotericin B ...
Sharon C A, Chen, Tania C, Sorrell
openaire   +2 more sources

Antifungal Agents

2015
Antifungal drugs used to treat serious fungal disease fall primarily into three drug classes. These classes include the azoles, echinocandins, and polyenes. Both azoles and polyenes target the cell membrane while echinocandins specifically target cell-wall synthesis. Amphotericin B is the primary drug in the polyene arsenal and is considered fungicidal,
Peter Davey   +3 more
  +5 more sources

Home - About - Disclaimer - Privacy